Literature DB >> 3320096

Varying occurrence of gastroduodenal immunoreactive pancreatic secretory trypsin inhibitor.

M Bohe1, C G Lindström, K Ohlsson.   

Abstract

Operative specimens from various parts of gastroduodenal mucosa were analysed for immunoreactive pancreatic secretory trypsin inhibitor (PSTI) using a peroxidase-antiperoxidase method. Normal gastric mucosa exhibited a varying degree of PSTI immunoreactivity, which was more pronounced in the foveolar cells of gastric mucosa of fundus type than in the non-pepsinogen producing antrum-pyloric mucosa. With the exception of metaplastic Paneth cells and some goblet cells, the intracellular content of PSTI was low in gastric mucosa with intestinal metaplasia. These findings may indicate that a PSTI immunoreactive substance has a role in the normal defence of the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3320096      PMCID: PMC1141237          DOI: 10.1136/jcp.40.11.1345

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

2.  Primary amino acid sequence similarity between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of porcine secretin family.

Authors:  L A Scheving
Journal:  Arch Biochem Biophys       Date:  1983-10-15       Impact factor: 4.013

3.  Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases.

Authors:  K Matsuda; M Ogawa; A Murata; T Kitahara; G Kosaki
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1983-05

4.  Distribution of antileukoprotease in upper respiratory mucosa.

Authors:  U Fryksmark; K Ohlsson; A Polling; H Tegner
Journal:  Ann Otol Rhinol Laryngol       Date:  1982 May-Jun       Impact factor: 1.547

5.  Purification and immunochemical quantitation of human pancreatic secretory trypsin inhibitor.

Authors:  A Eddeland; K Ohlsson
Journal:  Scand J Clin Lab Invest       Date:  1978-05       Impact factor: 1.713

6.  Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man.

Authors:  W H Marks; K Ohlsson; A Polling
Journal:  Scand J Gastroenterol       Date:  1984-07       Impact factor: 2.423

7.  Elevated pancreatic secretory trypsin inhibitor levels during severe inflammatory disease, renal insufficiency, and after various surgical procedures.

Authors:  A Lasson; A Borgström; K Ohlsson
Journal:  Scand J Gastroenterol       Date:  1986-12       Impact factor: 2.423

8.  Epidermal growth factor inhibits cysteamine-induced duodenal ulcers.

Authors:  P Kirkegaard; P S Olsen; S S Poulsen; E Nexø
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

9.  Immunoreactive pancreatic secretory trypsin inhibitor in gynecological diseases.

Authors:  A Murata; M Ogawa; K Matsuda; N Matsuura; G Kosaki; M Inoue; G Ueda; K Kurachi
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1983-09

10.  Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats.

Authors:  A Dembiński; H Gregory; S J Konturek; M Polański
Journal:  J Physiol       Date:  1982-04       Impact factor: 5.182

View more
  8 in total

1.  Immunoreactive pancreatic secretory trypsin inhibitor in normal, inflammatory and neoplastic gallbladders.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1991-02

2.  Production and secretion of pancreatic secretory trypsin inhibitor in normal human small intestine.

Authors:  H Bohe; M Bohe; E Lundberg; A Polling; K Ohlsson
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

3.  Immunohistochemical demonstration of pancreatic secretory trypsin inhibitor in normal and neoplastic colonic mucosa.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  J Clin Pathol       Date:  1990-11       Impact factor: 3.411

4.  Absence of trypsinogen autoactivation and immunolocalization of pancreatic secretory trypsin inhibitor in acinar cells in vitro.

Authors:  A E Arias; T Böldicke; M Bendayan
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

5.  Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice.

Authors:  T C Freeman; R J Playford; C Quinn; K Beardshall; L Poulter; J Young; J Calam
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

6.  Pancreatic secretory trypsin inhibitor in human Brunner's glands.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

7.  Quantification of pancreatic secretory trypsin inhibitor in colonic carcinoma and normal adjacent colonic mucosa.

Authors:  H Bohe; M Bohe; P Jönsson; C Lindström; K Ohlsson
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

Review 8.  Metaplastic Paneth Cells in Extra-Intestinal Mucosal Niche Indicate a Link to Microbiome and Inflammation.

Authors:  Rajbir Singh; Iyshwarya Balasubramanian; Lanjing Zhang; Nan Gao
Journal:  Front Physiol       Date:  2020-03-31       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.